Stock IMRX IMMUNEERING CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Immuneering Corporation

Equities

IMRX

US45254E1073

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
1.43 USD -4.67% Intraday chart for Immuneering Corporation -19.21% -80.54%
Apr. 09 Immuneering Corporation Presents Preclinical Data At the American Association for Cancer Research Annual Meeting CI
Apr. 02 Mizuho Adjusts Price Target on Immuneering to $8 From $20 on Revised Revenue Assumptions for Lead Asset IMM-1-104, Keeps Buy Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. IMRX Stock
  4. Revisions Immuneering Corporation